NanoViricides, Inc. (NNVC.OB) Reports Progress in Drug Development Programs and Fiscal Responsibility
One company that has been gaining acclaim in their industry, but not on Wall Street, is NanoViricides. An odd series of events is causing confusion in the marketplace. NanoViricides is a development stage company that is creating special purpose nanomaterials for viral therapy. Based in Connecticut, the young company has gained raved reviews for its HIVCode which could result in a functional cure for HIV/AIDS. Besides the HIVCode, NanoViricides has been making progress in all aspects of their company. NanoViricides has reported that it is well-financed into the future and its game changing anti-viral and drug programs have continued to…